Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests

Abstract Objective: To evaluate whether the introduction of a national, co‐ordinated screening program using the faecal occult blood test represents ‘value‐for‐money’ from the perspective of the Australian Government as third‐party funder. Methods: The annual equivalent costs and consequences of a b...

Full description

Bibliographic Details
Main Authors: Christine A. Stone, Robert C. Carter, Theo Vos, James St John
Format: Article
Language:English
Published: Wiley 2004-06-01
Series:Australian and New Zealand Journal of Public Health
Online Access:https://doi.org/10.1111/j.1467-842X.2004.tb00707.x
id doaj-e0427e3ee31540f5bcd41b6c1ea9e69f
record_format Article
spelling doaj-e0427e3ee31540f5bcd41b6c1ea9e69f2020-11-24T22:26:29ZengWileyAustralian and New Zealand Journal of Public Health1326-02001753-64052004-06-0128327328210.1111/j.1467-842X.2004.tb00707.xColorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood testsChristine A. Stone0Robert C. Carter1Theo Vos2James St John3Public Health Group, Rural & Regional Health & Aged Care Services, Department of Human Services, VictoriaHealth Economics Group and Program Evaluation Unit, School of Population Health, The University of Melbourne, VictoriaSchool of Population Health, University of QueenslandNational Cancer Control Initiative, VictoriaAbstract Objective: To evaluate whether the introduction of a national, co‐ordinated screening program using the faecal occult blood test represents ‘value‐for‐money’ from the perspective of the Australian Government as third‐party funder. Methods: The annual equivalent costs and consequences of a biennial screening program in ‘steady‐state’ operation were estimated for the Australian population using 1996 as the reference year. Disability‐adjusted life years (DALYs) and the years of life lost (YLLs) averted, and the health service costs were modelled, based on the epidemiology and the costs of colorectal cancer in Australia together with the mortality reduction achieved in randomised controlled trials. Uncertainty in the model was examined using Monte Carlo simulation methods. Results: We estimate a minimum or ‘base program’ of screening those aged 55 to 69 years could avert 250 deaths per annum (95% uncertainty interval 99–400), at a gross cost of $A55 million (95% UI $A46 million to $A96 million) and a gross incremental cost‐effectiveness ratio of $A17,000/DALY (95% UI $A13,000/DALY to $A52,000/DALY). Extending the program to include 70 to 74‐year‐olds is a more effective option (cheaper and higher health gain) than including the 50 to 54‐year‐olds. Conclusions: The findings of this study support the case for a national program directed at the 55 to 69‐year‐old age group with extension to 70 to 74‐year‐olds if there are sufficient resources. The pilot tests recently announced in Australia provide an important opportunity to consider the age range for screening and the sources of uncertainty, identified in the modelled evaluation, to assist decisions on implementing a full national program.https://doi.org/10.1111/j.1467-842X.2004.tb00707.x
collection DOAJ
language English
format Article
sources DOAJ
author Christine A. Stone
Robert C. Carter
Theo Vos
James St John
spellingShingle Christine A. Stone
Robert C. Carter
Theo Vos
James St John
Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests
Australian and New Zealand Journal of Public Health
author_facet Christine A. Stone
Robert C. Carter
Theo Vos
James St John
author_sort Christine A. Stone
title Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests
title_short Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests
title_full Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests
title_fullStr Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests
title_full_unstemmed Colorectal cancer screening in Australia: An economic evaluation of a potential biennial screening program using faecal occult blood tests
title_sort colorectal cancer screening in australia: an economic evaluation of a potential biennial screening program using faecal occult blood tests
publisher Wiley
series Australian and New Zealand Journal of Public Health
issn 1326-0200
1753-6405
publishDate 2004-06-01
description Abstract Objective: To evaluate whether the introduction of a national, co‐ordinated screening program using the faecal occult blood test represents ‘value‐for‐money’ from the perspective of the Australian Government as third‐party funder. Methods: The annual equivalent costs and consequences of a biennial screening program in ‘steady‐state’ operation were estimated for the Australian population using 1996 as the reference year. Disability‐adjusted life years (DALYs) and the years of life lost (YLLs) averted, and the health service costs were modelled, based on the epidemiology and the costs of colorectal cancer in Australia together with the mortality reduction achieved in randomised controlled trials. Uncertainty in the model was examined using Monte Carlo simulation methods. Results: We estimate a minimum or ‘base program’ of screening those aged 55 to 69 years could avert 250 deaths per annum (95% uncertainty interval 99–400), at a gross cost of $A55 million (95% UI $A46 million to $A96 million) and a gross incremental cost‐effectiveness ratio of $A17,000/DALY (95% UI $A13,000/DALY to $A52,000/DALY). Extending the program to include 70 to 74‐year‐olds is a more effective option (cheaper and higher health gain) than including the 50 to 54‐year‐olds. Conclusions: The findings of this study support the case for a national program directed at the 55 to 69‐year‐old age group with extension to 70 to 74‐year‐olds if there are sufficient resources. The pilot tests recently announced in Australia provide an important opportunity to consider the age range for screening and the sources of uncertainty, identified in the modelled evaluation, to assist decisions on implementing a full national program.
url https://doi.org/10.1111/j.1467-842X.2004.tb00707.x
work_keys_str_mv AT christineastone colorectalcancerscreeninginaustraliaaneconomicevaluationofapotentialbiennialscreeningprogramusingfaecaloccultbloodtests
AT robertccarter colorectalcancerscreeninginaustraliaaneconomicevaluationofapotentialbiennialscreeningprogramusingfaecaloccultbloodtests
AT theovos colorectalcancerscreeninginaustraliaaneconomicevaluationofapotentialbiennialscreeningprogramusingfaecaloccultbloodtests
AT jamesstjohn colorectalcancerscreeninginaustraliaaneconomicevaluationofapotentialbiennialscreeningprogramusingfaecaloccultbloodtests
_version_ 1725753353724493824